1Pardridge WM. The Blood-Brain Barrier: Bottleneck in Brain Drug Development [J]. Neurorx, 2005, 2(1): 3-14.
2Song BW, Vinters HV, Wu D, et al. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood- brain barrier delivery vector [J]. J Pharmacol Exp Ther, 2002, 301(2) : 605-610.
3Widera A, Norouziyan F. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery [J]. Advanced Drug Delivery Reviews, 2003, 55 (11): 1439-1466.
4Zhang Y, Pardridge WM. Delivery of beta galaetosidase to mouse brain via the blood-brain barrier transferrin receptor [J]. J Pharmacol Exp Ther, 2005, 313 (3): 1075-1081.
5Coloma MJ, Lee HJ, Kurihara A,et al. Transport across the primate blood brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin reeeptor[J]. Pharm Res, 2000, 17(4): 266-274.
6Mazel M, Clair P, Rousselle C, et al. Doxorubicin peptide conjugates overcome multidrug resistance [J]. Anticancer Drugs, 2001, 12(5):107-116.
7Thoren PE, Persson D, Karlsson M, et al. The antennapedia peptide penetratin translocates across lipid bilayers the first direct observation [J]. FEBS Lett, 2000, 482 (3): 265-273.
8Derossi D, Chassaing G, Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery [J]. Trends Cellular Biol, 1998, 8(2): 84-87.
9Schwarze SR, Ho A, Vocero Akbam A. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 1999, 285 (5433): 1569-1572.
10Galipeau J, Li H, Paquin A, et al. Vesicular stomatitis virus G pseudotyped retrovector? mediates effective in vivo suicide gene delivery in experimental brain cancer[J]. Cancer Res. 1999, 59(9): 2384-2394.
